Omnicare, Inc. (OCR) Tops Q3 EPS by 2c, Posts FY11 Guidance
Tweet
Share
E-mailGet Alerts OCR Hot Sheet
Price: $97.90 --0%
Financial Fact:
Comprehensive income: 35.01M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Comprehensive income: 35.01M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Omnicare, Inc. (NYSE: OCR) reported Q3 EPS of $0.54, $0.02 better than the analyst estimate of $0.52. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.54 billion.
Omnicare, Inc. sees FY2011 EPS of $2.09-$2.13, versus the consensus of $2.11. Omnicare, Inc. sees FY2011 revenue of $6.-$6.1 billion, versus the consensus of $6.15 billion.
Omnicare, Inc. sees FY2011 EPS of $2.09-$2.13, versus the consensus of $2.11. Omnicare, Inc. sees FY2011 revenue of $6.-$6.1 billion, versus the consensus of $6.15 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Twin Disc (TWIN) Tops Q4 EPS by 16c
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
